https://investors.exagen.com/ 2026-03-10T12:02:26-04:00 daily 1.0 https://investors.exagen.com/committee-details/audit-committee 2025-07-31T20:06:30-04:00 0.5 https://investors.exagen.com/committee-details/compensation-committee 2025-07-31T20:06:34-04:00 0.5 https://investors.exagen.com/committee-details/nominating-and-governance-committee 2025-07-31T20:06:45-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-3rd-quarter-2019-financial-results 2019-11-19T13:48:01-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-canaccord-genuity-13th-annual-medtech-diagnostics-forum 2019-11-07T12:35:02-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-31st-annual-piper-jaffray-healthcare-conference 2019-11-22T14:34:10-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-present-cowen-and-company-40th-annual-healthcare-conference 2020-02-18T15:11:41-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fourth-quarter-and-year-end-2019-financial-results 2020-03-11T11:17:24-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-first-quarter-2020-financial-results-conference-call 2020-04-27T12:57:40-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-william-blair-40th-annual-growth-stock-conference 2020-05-26T13:05:16-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-second-quarter-2020-financial-results-conference-call 2020-09-01T13:10:25-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-canaccord-genuity-conference-fireside-chat 2020-09-01T13:10:31-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-2020-william-blair-west-coast-med-tech-field-trip 2020-09-08T14:51:47-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-2020-cantor-fitzgerald-global-healthcare-conference 2020-09-11T13:08:33-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-third-quarter-2020-financial-results-conference-call 2020-11-03T11:26:22-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-2020-stifel-virtual-healthcare-conference 2020-11-13T15:47:49-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fireside-chat-2020-canaccord-genuity-virtual-medtech-and-diagnostics 2020-11-18T11:16:45-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-piper-sandler-32nd-annual-virtual-healthcare-conference 2020-11-25T12:13:16-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-evercore-isi-3rd-annual-healthconx-conference 2020-11-18T18:41:43-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-2021-icr-conference 2021-01-05T16:18:27-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fourth-quarter-2020-financial-results-conference-call 2021-03-16T16:38:34-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-first-quarter-2021-financial-results-conference-call 2021-04-27T16:34:34-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-william-blair-41st-annual-growth-stock-conference 2021-05-24T16:42:33-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-second-quarter-2021-financial-results-conference-call 2021-07-26T16:13:54-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-inc-fireside-chat-canaccord-genuity-41st-annual-growth-conference 2021-08-05T15:12:14-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-inc-fireside-chat-cantor-fitzgerald-virtual-global-healthcare 2021-09-13T16:45:07-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-third-quarter-2021-financial-results-conference-call 2021-11-05T19:38:31-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-2021-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health 2021-11-09T17:57:10-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-piper-sandler-33rd-annual-virtual-healthcare-conference 2022-02-03T13:30:35-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fourth-quarter-2021-financial-results-conference-call 2022-03-20T21:09:38-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-inc-2022-keybanc-capital-markets-life-sciences-and-medtech-investor 2022-03-20T21:11:06-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-first-quarter-2022-financial-results-conference-call 2022-04-27T16:46:44-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-inc-participate-investor-summit-groups-q2-conference 2022-04-27T16:47:59-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-second-quarter-2022-financial-results-conference-call 2022-07-22T14:17:04-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-inc-canaccord-genuity-42nd-annual-growth-conference 2022-07-25T17:57:45-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-third-quarter-2022-financial-results-conference-call 2022-11-01T12:38:39-04:00 0.5 https://investors.exagen.com/events/event-details/cowen-43rd-annual-health-care-conference 2023-02-27T11:52:21-05:00 0.5 https://investors.exagen.com/events/event-details/keybanc-capital-markets-life-sciences-medtech-investor-forum 2023-02-27T11:53:18-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fourth-quarter-2022-financial-results-conference-call 2023-03-06T17:32:32-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-first-quarter-2023-financial-results-conference-call 2023-04-24T17:01:59-04:00 0.5 https://investors.exagen.com/events/event-details/william-blair-43rd-annual-growth-stock-conference 2023-05-30T16:49:46-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-second-quarter-2023-financial-results-conference-call 2023-07-25T19:24:52-04:00 0.5 https://investors.exagen.com/events/event-details/canaccord-genuity-43rd-annual-growth-conference 2023-07-26T16:59:42-04:00 0.5 https://investors.exagen.com/events/event-details/cantor-fitzgerald-global-healthcare-conference 2023-09-19T19:58:32-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-third-quarter-2023-financial-results-conference-call 2023-11-01T12:54:56-04:00 0.5 https://investors.exagen.com/events/event-details/canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum 2023-11-09T16:49:01-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-fourth-quarter-2023-financial-results-conference-call 2024-03-07T17:06:30-05:00 0.5 https://investors.exagen.com/events/event-details/exagen-first-quarter-2024-financial-results-conference-call 2024-05-02T16:35:00-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-second-quarter-2024-financial-results-conference-call 2024-08-01T15:57:23-04:00 0.5 https://investors.exagen.com/events/event-details/canaccord-genuity-44th-annual-growth-conference-private-company-showcase 2024-08-02T17:02:49-04:00 0.5 https://investors.exagen.com/events/event-details/exagen-third-quarter-2024-financial-results-conference-call 2024-10-30T19:50:01-04:00 0.5 https://investors.exagen.com/events/event-details/cg-medtech-diagnostics-and-digital-health-services-forum 2024-11-18T19:11:41-05:00 0.5 https://investors.exagen.com/events/event-details/td-cowen-45th-annual-health-care-conference 2025-03-03T13:58:33-05:00 0.5 https://investors.exagen.com/events/event-details/q4-2024-earnings-call 2025-03-03T13:57:36-05:00 0.5 https://investors.exagen.com/events/event-details/q1-2025-earnings-call 2025-04-22T13:44:31-04:00 0.5 https://investors.exagen.com/events/event-details/q2-2025-earnings-call 2025-07-18T19:03:42-04:00 0.5 https://investors.exagen.com/events/event-details/q3-2025-earnings-call 2025-10-21T16:59:47-04:00 0.5 https://investors.exagen.com/events/event-details/q4-2025-earnings-call 2026-03-10T00:43:53-04:00 0.5 https://investors.exagen.com/events/event-details/keybank-capital-markets-healthcare-forum 2026-03-03T12:43:00-05:00 0.5 https://investors.exagen.com/events/event-details/roth-capital-conference 2026-03-03T12:43:06-05:00 0.5 https://investors.exagen.com/investor-relations 2026-03-10T12:02:26-04:00 0.8 https://investors.exagen.com/press-releases 2019-06-19T06:26:32-04:00 0.8 https://investors.exagen.com/events 2022-08-05T19:22:21-04:00 0.8 https://investors.exagen.com/events-and-presentations/presentations 2025-06-09T14:10:23-04:00 0.8 https://investors.exagen.com/corporate-governance/governance-overview 2019-09-18T14:35:12-04:00 0.8 https://investors.exagen.com/corporate-governance/committee-composition 2024-08-07T15:45:52-04:00 0.8 https://investors.exagen.com/financial-information/annual-reports 2022-03-23T18:33:10-04:00 0.8 https://investors.exagen.com/financial-information/analyst-coverage 2021-04-09T12:24:00-04:00 0.8 https://investors.exagen.com/stock-information/stock-quote-chart 2019-09-18T14:46:00-04:00 0.8 https://investors.exagen.com/shareholder-services/investor-faqs 2017-12-29T16:32:56-05:00 0.8 https://investors.exagen.com/shareholder-services/email-alerts 2017-12-29T16:39:42-05:00 0.8 https://investors.exagen.com/shareholder-services/rss-feeds 2017-12-29T16:26:13-05:00 0.8 https://investors.exagen.com/investor-contacts 2019-06-19T08:32:33-04:00 0.8 https://investors.exagen.com/sec-filings 2019-07-12T23:32:11-04:00 0.8 https://investors.exagen.com/esg-reports 2022-04-15T17:05:50-04:00 0.8 https://investors.exagen.com/news-releases/news-release-details/avise-ctd-blood-test-helps-rheumatologists-and-their-patients 2019-06-18T18:22:58-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/new-biomarker-available-offer-insight-thrombosis-lupus-sufferers 2019-06-19T09:33:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/jeffrey-thomas-elliott-cfa-joins-exagens-board-directors 2019-06-19T09:38:00-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-and-lupus-foundation-america-partner-new-initiative 2019-06-25T14:04:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-present-cowen-and-company-39th-annual-health-care 2019-06-25T14:06:06-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-enters-second-year-agreement-gsk-drive-greater-awareness 2019-06-25T14:07:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-diagnostics-present-piper-jaffray-30th-annual-heathcare 2019-06-25T15:42:20-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-diagnostics-present-canaccord-genuity-medical 2019-06-25T15:44:28-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-launch-novel-biomarker-pc4d-associated-thrombosis-lupus 2019-06-25T16:20:26-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-featured-eight-scientific-presentations-2018-acrarhp 2019-06-25T17:14:31-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-maker-avise-testing-announces-first-blood-test-anti-carp 2019-06-25T17:16:31-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-completes-226-million-financing 2019-09-09T16:18:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-board-directors-its-appointment-chet-burrell 2019-09-09T16:20:25-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-and-university-washington-collaborate-lupus-and 2019-09-09T16:21:52-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-pricing-initial-public-offering 2019-09-18T19:26:51-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-closing-initial-public-offering-and-full 2019-09-24T18:29:31-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-publication-two-key-studies-validating-clinical 2019-10-15T08:15:33-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-be-honored-national-research-innovation-award-lupus 2019-10-21T08:15:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/aviser-mtx-test-exagen-supports-horizon-therapeutics-plc 2019-10-24T08:20:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-featured-nine-scientific-presentations-2019-acrarhp 2019-10-28T08:15:30-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-2019-financial-results-november 2019-10-29T08:02:14-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-participate-canaccord-genuity-13th-annual-medtech 2019-11-07T08:14:47-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-third-quarter-2019-results 2019-11-12T16:06:16-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-31st-annual-piper-jaffray-healthcare 2019-11-20T05:15:26-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-262-million-debt-refinancing 2019-11-21T08:25:42-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-extends-agreement-gsk-third-year-drive-greater-awareness 2019-11-22T08:25:26-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/national-experts-autoimmunity-tapped-serve-exagens-scientific 2019-12-10T08:10:31-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-addition-russell-3000r-and-2000r-indexes 2019-12-16T08:25:27-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-present-cowen-and-company-40th-annual-healthcare 2020-02-18T08:25:49-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-partners-three-california-medical-groups-offer-avise 2020-03-09T08:20:40-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-fourth-quarter-and-year-end-2019-financial 2020-03-11T08:25:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-partners-sonora-quest-laboratories-offer-avise 2020-03-16T08:19:45-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-appoints-debra-jeske-zack-md-phd-chief-medical-officer 2020-03-24T08:25:31-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-fourth-quarter-and-full-year-2019-results 2020-03-25T16:06:00-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-first-quarter-financial-results-may-11-2020 2020-04-27T08:25:46-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-first-quarter-2020-results 2020-05-11T16:07:54-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-present-william-blair-40th-annual-growth-stock-conference 2020-05-26T08:25:42-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-clinical-trial-conducted-major-academic 2020-06-03T08:25:39-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-and-ohio-state-innovation-foundation-announce-exclusive 2020-06-17T08:25:48-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-second-quarter-financial-results-july-28-2020 2020-07-16T10:45:49-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-avise-testing-now-covered-and-network-tricare-east 2020-07-27T16:06:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-second-quarter-2020-results 2020-07-28T07:01:44-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-present-canaccord-genuity-40th-annual-growth-conference 2020-07-30T16:25:54-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-collaboration-hospital-special-surgery-hss 2020-08-03T16:06:07-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-participate-2020-cantor-fitzgerald-virtual-global 2020-09-03T16:06:44-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-launches-test-aid-detection-anca-associated-vasculitis 2020-09-21T08:25:47-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-appoints-wendy-johnson-board-directors 2020-09-23T16:10:37-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-agreement-provider-network-america 2020-09-29T08:25:43-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/new-data-demonstrates-economic-benefit-exagens-aviser-lupus-test 2020-10-12T16:06:17-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-showcases-six-scientific-presentations-acrs-first-virtual 2020-10-21T16:06:43-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-financial-results-november-10-2020 2020-10-27T16:06:07-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-study-evaluate-emergence-autoimmune 2020-11-02T08:25:39-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-november-investor-conferences 2020-11-09T08:25:41-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-third-quarter-2020-results 2020-11-10T16:09:25-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-and-gsk-partner-4th-straight-year-driving-greater 2020-11-16T08:25:39-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-december-investor-conferences 2020-11-18T16:06:40-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-partners-oregons-st-charles-health-system-offer 2021-01-04T16:06:31-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2021-icr-conference 2021-01-05T16:06:03-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-preliminary-fourth-quarter-2020-testing 2021-01-10T18:00:47-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-partners-bostons-tufts-medical-center-offer-aviser 2021-01-21T16:06:29-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-btig-medtech-digital-health-life-science 2021-02-03T16:06:50-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-cowen-41st-annual-health-care-conference 2021-02-22T16:06:12-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-fourth-quarter-and-full-year-financial-results 2021-03-02T08:05:26-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-fourth-quarter-and-full-year-2020-results 2021-03-16T16:06:22-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-proposed-public-offering-common-stock 2021-03-22T16:06:49-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-pricing-public-offering-common-stock 2021-03-22T22:01:59-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-closing-public-offering-common-stock 2021-03-25T16:16:49-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-study-long-term-effects-covid-19-infection 2021-03-29T08:25:54-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-first-quarter-2021-financial-results-may-11-2021 2021-04-27T16:07:14-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-new-campaign-and-initiatives-lupus-awareness 2021-05-03T08:25:51-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-allegheny-health-network-research-institute-and-ahn 2021-05-04T16:08:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-first-quarter-2021-results 2021-05-11T16:08:42-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-william-blair-41st-annual-growth-stock 2021-05-24T16:06:19-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-elects-frank-stokes-board-directors 2021-06-18T08:29:37-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/aviser-lupus-test-demonstrates-statistically-significant 2021-07-13T16:06:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-second-quarter-2021-financial-results-august-9 2021-07-26T16:07:43-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-canaccord-genuity-41st-annual-growth 2021-07-29T08:25:40-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-appoints-ana-hooker-board-directors 2021-07-30T08:25:45-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-second-quarter-2021-results 2021-08-09T16:11:04-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2021-cantor-fitzgerald-virtual-global 2021-09-13T16:16:17-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-showcases-eight-scientific-presentations-acrs-virtual 2021-10-21T16:07:10-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-272-million-debt-refinancing 2021-10-25T08:25:56-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-coverage-inland-empire-health-plan-partnering 2021-10-27T08:25:46-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-2021-financial-results-november-10 2021-10-27T16:09:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2021-canaccord-genuity-virtual-medtech 2021-11-04T16:12:54-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-third-quarter-2021-results 2021-11-10T16:12:23-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-piper-sandler-33rd-annual-virtual 2021-11-17T16:07:44-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-and-queen-mary-university-london-announce-exclusive 2022-01-09T12:00:50-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2022-btig-medtech-digital-health-life 2022-02-02T16:07:07-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-fourth-quarter-and-full-year-financial-results-0 2022-03-08T16:08:32-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2022-keybanc-capital-markets-life 2022-03-09T16:07:57-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-new-rheumatoid-arthritis-scientific-advisory 2022-03-16T16:07:35-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-fourth-quarter-and-full-year-2021-results 2022-03-22T16:08:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-network-benefit-additional-227-million-lives 2022-03-22T16:09:31-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-network-access-evolutions-healthcare-systems 2022-03-30T08:26:04-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-investor-summit-groups-q2-conference 2022-04-20T16:05:22-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-first-quarter-2022-financial-results-may-11-2022 2022-04-25T16:05:36-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-five-week-campaign-lupus-awareness-month 2022-05-01T12:00:25-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-new-pla-code-and-medicare-pricing 2022-05-11T16:06:15-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-first-quarter-2022-results 2022-05-11T16:07:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-coverage-alivio-health-partnering-provide 2022-05-16T16:05:38-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-william-blair-42nd-annual-growth-stock 2022-05-26T16:05:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-expands-coverage-medincrease 2022-06-09T08:27:25-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-releases-largest-comparative-utility-study-lupus 2022-07-05T08:25:22-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-second-quarter-2022-financial-results-august-4 2022-07-21T16:05:30-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-canaccord-genuity-42nd-annual-growth 2022-07-25T16:05:36-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-second-quarter-2022-results 2022-08-04T16:05:37-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-initiates-study-predict-rheumatoid-arthritis-drug 2022-08-04T16:06:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-collaboration-leads-characterization-broad 2022-09-01T16:05:56-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-acceptance-multiple-abstracts-acr-2022-annual 2022-09-20T16:05:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-appointment-andrew-l-concoff-md-facr-caqsm 2022-10-04T08:25:18-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-appointment-john-aballi-ceo 2022-10-17T09:00:47-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-2022-financial-results-november-14 2022-10-31T16:05:23-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-fourth-quarter-investor-conferences 2022-11-08T16:05:41-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-third-quarter-2022-results 2022-11-14T16:08:55-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-elects-tina-s-nova-phd-executive-chair-board 2023-01-23T09:01:22-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2023-btig-medtech-digital-health-life 2023-01-30T16:06:24-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-upcoming-march-conferences 2023-02-27T09:00:53-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-fourth-quarter-and-full-year-financial-results-1 2023-03-06T16:05:24-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-fourth-quarter-and-full-year-2022-results 2023-03-20T16:05:35-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-first-quarter-2023-financial-results-may-15-2023 2023-04-24T16:05:42-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-campaign-lupus-awareness-month 2023-05-01T16:05:30-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-first-quarter-2023-results 2023-05-15T16:05:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-william-blair-43rd-annual-growth-stock 2023-05-30T09:01:08-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-appoints-paul-kim-board-directors 2023-07-24T16:05:21-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-second-quarter-2023-financial-results-august-7 2023-07-25T16:05:28-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-canaccord-genuity-43rd-annual-growth 2023-07-26T16:05:19-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-second-quarter-2023-results 2023-08-07T08:00:35-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2023-cantor-fitzgerald-global-healthcare 2023-09-12T16:05:35-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-acceptance-multiple-abstracts-acr-2023-annual 2023-09-28T16:05:23-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-2023-financial-results-november-13 2023-10-30T16:05:32-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2023-canaccord-genuity-medtech 2023-11-02T16:07:28-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-and-johns-hopkins-university-announce-license 2023-11-09T16:06:07-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-third-quarter-2023-results 2023-11-13T16:05:52-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-select-preliminary-full-year-2023-results 2024-01-07T12:00:21-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2024-btig-medtech-digital-health-life 2024-01-30T16:05:33-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-fourth-quarter-2023-and-full-year-financial 2024-03-07T16:07:37-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-keybanc-capital-markets-life-sciences 2024-03-08T09:00:16-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-fourth-quarter-and-full-year-2023 2024-03-18T08:00:49-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-changes-board-directors 2024-04-26T08:30:30-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-first-quarter-2024-results-may-13-2024 2024-04-30T16:05:56-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-campaign-lupus-awareness-month-0 2024-05-06T16:06:29-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-first-quarter-2024-results-raises 2024-05-13T08:00:50-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-second-quarter-2024-results-august-5-2024 2024-07-22T09:00:50-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-appoints-jeffrey-g-black-new-chief-financial-officer 2024-08-01T09:00:46-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-canaccord-genuity-44th-annual-growth 2024-08-02T09:00:24-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-second-quarter-2024-results-raises 2024-08-05T08:00:58-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-2024-cantor-global-healthcare-conference 2024-09-04T16:07:17-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-acceptance-five-abstracts-2024-american-college 2024-10-21T16:05:35-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announce-third-quarter-2024-results-november-12-2024 2024-10-29T16:05:41-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-third-quarter-2024-results 2024-11-12T08:02:10-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-fourth-quarter-investor-conferences-0 2024-11-13T16:05:36-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-completes-validation-and-regulatory-submission-new 2024-11-14T16:36:41-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-achieves-key-milestone-1000000th-patient-tested 2024-12-12T09:00:32-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-secures-conditional-ny-state-approval-new-lupus-and 2025-01-12T12:00:28-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-upcoming-investor-conferences 2025-02-04T16:05:28-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announce-fourth-quarter-and-full-year-2024-financial 2025-02-25T16:05:45-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-fourth-quarter-and-full-year-2024 2025-03-11T08:01:18-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announce-first-quarter-2025-financial-results-may-5 2025-04-21T16:05:18-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-senior-secured-credit-facility-perceptive 2025-04-28T09:00:23-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-record-q1-2025-revenue-driven-growth-average 2025-05-05T08:01:05-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-proposed-public-offering-common-stock-0 2025-05-07T16:06:11-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-prices-public-offering-common-stock 2025-05-08T08:30:42-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-closing-202-million-public-offering 2025-05-09T16:05:28-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/michael-mahler-phd-joins-exagen-chief-scientific-officer-enhance 2025-06-23T09:02:21-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announce-second-quarter-2025-financial-results-july 2025-07-15T16:05:40-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-appoints-chas-mckhann-board-directors 2025-07-17T16:05:27-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-q2-2025-results 2025-07-29T08:02:21-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-third-quarter-investor-conferences 2025-08-06T16:06:22-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announce-third-quarter-2025-financial-results 2025-10-21T16:05:34-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-announces-acceptance-six-abstracts-2025-american-college 2025-10-23T09:15:33-04:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-q3-2025-results 2025-11-04T08:01:44-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-fourth-quarter-investor-conferences-1 2025-11-11T09:01:29-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announces-select-preliminary-2025-financial-results 2026-01-11T15:00:32-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-announce-fourth-quarter-and-full-year-2025-financial 2026-02-24T09:00:39-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-participate-upcoming-investor-conferences-0 2026-03-03T09:00:38-05:00 0.5 https://investors.exagen.com/news-releases/news-release-details/exagen-inc-reports-strong-fourth-quarter-and-full-year-2025 2026-03-10T08:02:29-04:00 0.5 https://investors.exagen.com/sec-filings/sec-filing/d/0001567619-19-002115 2019-02-01T12:26:47-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-1/0001193125-19-228011 2019-08-23T17:14:38-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-1a/0001193125-19-240403 2019-09-09T06:24:21-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-a12b/0001193125-19-244881 2019-09-13T16:49:42-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-1mef/0001193125-19-248504 2019-09-18T17:59:06-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023866 2019-09-18T21:25:24-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023870 2019-09-18T21:27:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023868 2019-09-18T21:27:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023873 2019-09-18T21:31:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023879 2019-09-18T21:33:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023875 2019-09-18T21:33:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023885 2019-09-18T21:43:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023887 2019-09-18T21:45:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023889 2019-09-18T21:47:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023892 2019-09-18T21:49:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023895 2019-09-18T21:51:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023893 2019-09-18T21:51:28-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023897 2019-09-18T21:53:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0000899243-19-023899 2019-09-18T22:03:28-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/effect/9999999995-19-002124 2019-09-19T06:11:36-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b4/0001193125-19-250698 2019-09-20T16:18:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001193125-19-250784 2019-09-20T17:18:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024008 2019-09-20T18:54:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024012 2019-09-20T18:58:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024013 2019-09-20T18:58:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024016 2019-09-20T19:02:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024017 2019-09-20T19:02:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024019 2019-09-20T19:04:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001193125-19-252366 2019-09-23T17:36:55-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024081 2019-09-23T21:46:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024078 2019-09-23T21:46:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024082 2019-09-23T21:48:29-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024083 2019-09-23T21:50:23-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024084 2019-09-23T21:50:24-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-19-024086 2019-09-23T21:52:59-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001628280-19-013993 2019-11-12T16:49:21-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001628280-19-014001 2019-11-12T17:20:51-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001628280-19-014376 2019-11-21T08:29:28-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001628280-19-014462 2019-11-22T16:10:23-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000009 2020-01-09T17:04:19-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000012 2020-01-09T17:11:40-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000013 2020-01-09T17:15:40-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0001493152-20-001141 2020-01-27T10:18:40-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0000950142-20-000328 2020-02-07T16:37:56-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0001104659-20-021727 2020-02-14T16:33:26-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/drs/0000950123-19-000586 2020-03-14T18:41:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/drsa/0000950123-19-006014 2020-03-14T18:48:55-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000016 2020-03-18T16:09:44-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-021042 2020-03-24T19:54:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-021043 2020-03-24T19:54:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000024 2020-03-25T16:10:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-20-000026 2020-03-25T17:20:36-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001209191-20-021339 2020-03-26T18:59:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-021345 2020-03-26T19:21:58-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-021486 2020-03-27T18:10:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-20-001148 2020-04-15T13:07:53-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-024575 2020-04-15T20:36:50-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001274737-20-000032 2020-04-29T16:17:53-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001274737-20-000031 2020-04-29T16:18:03-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000036 2020-05-11T16:09:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-20-000037 2020-05-11T17:19:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-031883 2020-05-22T20:11:41-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-032932 2020-05-29T16:37:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-036167 2020-06-11T20:57:55-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000040 2020-06-19T08:29:05-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000043 2020-06-29T16:15:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000044 2020-06-29T16:15:19-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000062 2020-07-02T08:44:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000061 2020-07-02T08:44:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000063 2020-07-02T08:46:21-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000064 2020-07-02T08:48:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000065 2020-07-02T08:50:36-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000066 2020-07-02T08:56:01-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000070 2020-07-16T21:07:32-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000074 2020-07-28T08:17:39-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-20-000077 2020-07-28T08:38:52-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-047275 2020-08-18T18:02:17-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-049452 2020-09-03T17:02:43-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-050352 2020-09-14T20:41:36-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0001140361-20-020885 2020-09-18T16:50:15-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000080 2020-09-23T16:07:56-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-20-000087 2020-10-01T16:35:44-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-20-000088 2020-10-01T16:35:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-055322 2020-10-19T18:04:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000095 2020-11-10T16:13:43-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-20-000097 2020-11-10T17:19:55-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-3/0001274737-20-000098 2020-11-10T17:23:31-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-058001 2020-11-12T17:03:54-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-20-002506 2020-11-12T19:01:35-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/effect/9999999995-20-003249 2020-11-20T06:08:37-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-063272 2020-12-14T17:07:32-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-063548 2020-12-15T17:23:32-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-20-063805 2020-12-16T16:38:07-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001274737-20-000101 2020-12-19T00:17:23-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/upload/0000000000-20-010950 2020-12-19T00:17:25-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-20-000103 2020-12-28T16:09:02-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000004 2021-01-11T07:02:51-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-21-000066 2021-01-11T21:53:28-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-21-000106 2021-01-14T19:36:49-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-21-003854 2021-01-15T17:31:25-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-21-004370 2021-01-20T17:11:05-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-21-000211 2021-01-21T16:59:07-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000950142-21-000246 2021-01-26T18:32:00-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001209191-21-008669 2021-02-08T21:47:15-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0000814133-21-000064 2021-02-11T14:49:39-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001140361-21-004337 2021-02-11T16:18:22-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001493152-21-003529 2021-02-12T09:55:06-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001104659-21-022554 2021-02-16T06:43:04-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000950142-21-000614 2021-02-16T10:25:19-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13d/0001193125-21-054718 2021-02-24T16:38:37-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000009 2021-02-25T17:09:14-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000008 2021-02-25T17:09:28-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000010 2021-02-25T17:10:34-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000014 2021-03-16T16:12:19-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-21-000015 2021-03-16T17:24:39-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001193125-21-089541 2021-03-22T16:16:06-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000017 2021-03-22T16:22:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000021 2021-03-23T16:19:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001193125-21-091233 2021-03-23T16:32:02-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-21-000024 2021-03-25T20:20:02-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-ka/0001274737-21-000027 2021-04-01T16:35:55-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000814133-21-000075 2021-04-09T14:02:18-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001274737-21-000032 2021-04-27T16:17:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001274737-21-000033 2021-04-27T16:17:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000042 2021-05-11T16:09:47-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-21-000044 2021-05-11T17:12:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001274737-21-000045 2021-05-11T17:19:05-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000047 2021-05-17T21:20:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000062 2021-06-21T08:33:56-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-21-000064 2021-06-21T08:36:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000073 2021-06-21T08:40:04-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000072 2021-06-21T08:40:05-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000078 2021-06-21T08:42:22-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000077 2021-06-21T08:42:22-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000076 2021-06-21T08:42:23-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000075 2021-06-21T08:42:23-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000074 2021-06-21T08:42:24-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-21-026584 2021-06-29T17:14:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-10-053490 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/da/0001104659-11-028048 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-11-037028 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-11-053475 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-12-062751 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-12-073261 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001104659-13-075606 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-14-028869 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-15-013896 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-15-026680 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-15-038122 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-048645 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-070788 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-078129 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-082419 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-085750 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-16-090192 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-17-003883 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-17-011136 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-17-015405 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001140361-17-021394 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001213900-11-006258 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001213900-11-006808 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/d/0001274737-09-000004 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-03-046042 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-05-031650 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-06-007999 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-07-045398 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-08-021516 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/regdex/9999999997-08-033846 2021-07-09T20:00:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-21-000086 2021-07-30T08:27:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000085 2021-07-30T08:27:35-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000087 2021-07-30T08:30:17-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-21-031644 2021-08-04T18:30:54-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-21-031918 2021-08-06T16:28:23-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000093 2021-08-09T16:14:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-21-000094 2021-08-09T17:21:18-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000098 2021-08-27T08:27:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-21-000101 2021-09-07T08:27:17-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001193125-19-228909 2021-10-02T10:18:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/upload/0000000000-19-003274 2021-10-02T15:59:01-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001193125-19-245837 2021-10-02T23:06:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/drs/0000950123-14-007693 2021-10-02T23:17:35-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001193125-19-245830 2021-10-03T00:17:40-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000103 2021-10-19T16:07:23-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000106 2021-10-25T08:27:52-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-21-000113 2021-11-10T16:12:04-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-21-000115 2021-11-10T17:22:11-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0001085146-21-003439 2021-12-17T15:59:17-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0000935836-21-000696 2021-12-27T06:04:51-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000003 2022-01-10T08:27:28-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001085146-22-000219 2022-01-19T16:23:15-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001085146-22-000239 2022-01-20T10:48:21-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000950142-22-000525 2022-02-08T16:14:54-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000008 2022-02-08T16:24:37-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000009 2022-02-08T16:24:37-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000010 2022-02-08T16:26:01-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000011 2022-02-08T16:26:24-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001140361-22-004519 2022-02-10T16:17:33-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000814133-22-000075 2022-02-11T14:10:54-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000935836-22-000127 2022-02-14T06:22:15-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000902664-22-001607 2022-02-14T08:58:09-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001213900-22-007350 2022-02-14T13:12:38-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0001085146-22-001160 2022-02-15T09:50:00-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000016 2022-03-02T16:42:19-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000018 2022-03-02T16:43:57-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000017 2022-03-02T16:44:38-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000019 2022-03-02T16:44:43-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001628280-22-006886 2022-03-22T16:08:07-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001628280-22-006926 2022-03-22T17:23:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001628280-22-011111 2022-04-28T16:15:56-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001628280-22-011115 2022-04-28T16:20:28-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001628280-22-011124 2022-04-28T16:27:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000027 2022-05-11T16:07:13-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-22-000028 2022-05-11T17:13:42-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001274737-22-000030 2022-05-11T17:18:30-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000039 2022-06-21T08:32:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000042 2022-06-21T08:34:31-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000041 2022-06-21T08:34:31-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000040 2022-06-21T08:34:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000046 2022-06-21T08:37:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000045 2022-06-21T08:37:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000043 2022-06-21T08:37:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000044 2022-06-21T08:37:10-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000051 2022-08-04T16:14:02-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-22-000052 2022-08-04T17:19:19-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000064 2022-09-15T16:07:07-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001274737-22-000065 2022-09-15T16:07:13-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001843113-22-000010 2022-10-18T20:43:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001843113-22-000008 2022-10-18T20:43:58-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000067 2022-10-20T16:07:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000070 2022-11-14T16:11:27-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/nt-10-q/0001274737-22-000071 2022-11-14T16:14:36-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-qa/0001274737-22-000075 2022-11-21T16:10:31-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-22-000076 2022-11-21T16:11:21-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13g/0000935836-22-000623 2022-11-23T14:53:05-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-22-000080 2022-12-05T16:23:49-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-22-000083 2022-12-09T09:04:25-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000002 2023-01-09T09:02:58-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000004 2023-01-23T09:03:01-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001085146-23-000295 2023-01-23T17:27:04-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001140361-23-004169 2023-02-02T16:17:53-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001085146-23-000656 2023-02-06T12:26:02-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001213900-23-008860 2023-02-07T12:56:15-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000814133-23-000044 2023-02-09T17:05:08-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000007 2023-02-10T16:09:01-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000008 2023-02-10T16:13:12-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000935836-23-000139 2023-02-13T10:59:55-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000935836-23-000185 2023-02-13T15:48:11-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000902664-23-001705 2023-02-14T10:02:17-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000012 2023-03-01T16:12:46-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000011 2023-03-01T16:13:34-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000014 2023-03-03T16:42:54-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000013 2023-03-03T16:42:58-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000017 2023-03-20T16:07:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-23-000019 2023-03-20T17:32:52-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000024 2023-03-23T09:04:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001274737-23-000034 2023-04-28T16:07:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001274737-23-000035 2023-04-28T16:08:34-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/ars/0001274737-23-000036 2023-04-28T16:11:39-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000041 2023-05-04T09:03:21-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000046 2023-05-15T16:12:45-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-23-000049 2023-05-15T17:18:15-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001274737-23-000051 2023-05-18T16:09:07-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001274737-23-000054 2023-05-24T16:16:48-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000064 2023-06-13T16:39:46-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000061 2023-06-13T16:39:46-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000062 2023-06-13T16:39:46-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000063 2023-06-13T16:39:47-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000060 2023-06-13T16:39:47-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000067 2023-06-14T16:56:32-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000069 2023-06-20T16:34:17-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0000899243-23-015986 2023-06-20T17:06:33-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000074 2023-07-24T16:09:30-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000080 2023-07-26T16:09:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-23-000079 2023-07-26T16:09:45-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000085 2023-08-07T08:04:16-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-23-000088 2023-08-07T09:30:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000091 2023-09-06T17:08:06-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-23-000094 2023-10-18T16:11:19-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000096 2023-10-26T16:17:19-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000101 2023-11-13T16:08:59-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-23-000103 2023-11-13T17:33:50-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-3/0001628280-23-039459 2023-11-17T16:08:03-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000105 2023-11-17T16:33:14-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001274737-23-000108 2023-11-20T08:04:19-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-3a/0001274737-23-000111 2023-11-27T16:07:08-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001628280-23-040240 2023-11-29T17:12:46-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/effect/9999999995-23-003493 2023-11-30T06:10:13-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-23-000116 2023-12-11T16:06:44-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000006 2024-01-08T08:06:03-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/upload/0000000000-23-012816 2024-01-15T01:15:52-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001274737-23-000113 2024-01-15T01:16:46-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001140361-24-003118 2024-01-22T16:21:07-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001085146-24-000643 2024-02-02T15:18:43-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000009 2024-02-08T16:11:10-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000814133-24-000052 2024-02-09T17:12:38-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0001193125-24-032792 2024-02-13T06:15:34-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000935836-24-000145 2024-02-13T16:37:18-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000902664-24-001550 2024-02-14T07:15:14-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000935836-24-000187 2024-02-14T14:45:40-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000012 2024-02-22T16:12:30-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000013 2024-02-22T16:14:45-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000015 2024-03-04T16:10:51-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000017 2024-03-06T16:09:22-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000019 2024-03-18T08:03:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-24-000022 2024-03-18T09:33:38-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001274737-24-000028 2024-04-26T08:35:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000030 2024-04-26T08:35:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/ars/0001274737-24-000037 2024-04-26T09:27:16-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001274737-24-000038 2024-04-26T17:09:27-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000045 2024-05-13T08:08:48-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-24-000048 2024-05-13T09:30:42-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001274737-24-000050 2024-05-13T09:32:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000052 2024-05-16T20:12:08-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000056 2024-06-11T16:09:43-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000061 2024-06-12T16:08:07-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000062 2024-06-12T16:08:07-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000064 2024-06-12T16:10:18-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000063 2024-06-12T16:10:18-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-24-000067 2024-06-14T16:08:39-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000068 2024-06-14T16:08:45-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000071 2024-08-02T08:19:22-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-ka/0001274737-24-000074 2024-08-02T17:22:06-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000078 2024-08-05T08:03:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-24-000079 2024-08-05T09:18:26-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/144/0001972362-24-001107 2024-08-09T17:09:42-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000084 2024-09-04T18:15:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-24-000085 2024-09-04T18:17:38-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/144/0001972362-24-001400 2024-10-08T16:41:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-24-000091 2024-11-12T09:33:55-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-24-000092 2024-11-12T09:37:42-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000094 2024-11-18T18:35:47-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-24-000096 2024-11-19T19:32:11-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001140361-24-047978 2024-11-27T16:21:43-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/sc-13ga/0000950142-24-002927 2024-12-12T17:02:56-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000003 2025-01-13T08:04:05-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/0001140361-25-002371 2025-01-29T19:12:56-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4a/0001274737-25-000009 2025-02-25T21:05:21-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000011 2025-02-25T21:05:29-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000010 2025-02-25T21:05:43-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000013 2025-03-04T18:51:35-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000018 2025-03-11T08:09:01-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-25-000019 2025-03-11T09:29:25-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001140361-25-010700 2025-03-27T16:19:09-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0001140361-25-014389 2025-04-17T16:20:54-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001193125-25-100447 2025-04-28T16:10:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/def-14a/0001193125-25-105576 2025-04-30T06:16:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/defa14a/0001193125-25-105584 2025-04-30T06:18:37-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/ars/0001193125-25-105588 2025-04-30T06:26:03-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000023 2025-05-05T08:06:52-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-25-000026 2025-05-05T09:34:04-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001193125-25-114885 2025-05-07T16:10:44-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001193125-25-115946 2025-05-08T16:09:53-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/424b5/0001193125-25-115953 2025-05-08T16:10:47-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001193125-25-116881 2025-05-09T16:12:34-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0001085146-25-002967 2025-05-12T17:39:35-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-8/0001274737-25-000030 2025-05-20T16:44:50-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000036 2025-06-11T16:51:14-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000038 2025-06-12T17:46:49-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000040 2025-06-12T17:49:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000042 2025-06-12T17:55:04-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000046 2025-06-12T17:59:00-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001274737-25-000048 2025-06-12T18:52:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4a/0001274737-25-000051 2025-06-12T20:40:12-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/s-3/0001628280-25-032393 2025-06-20T16:22:57-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/effect/9999999995-25-002146 2025-07-03T06:11:44-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000055 2025-07-17T16:34:53-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000061 2025-07-29T08:04:40-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-25-000063 2025-07-29T09:25:28-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/upload/0000000000-25-006893 2025-08-02T00:07:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/corresp/0001628280-25-033488 2025-08-02T00:07:51-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0001415889-25-021708 2025-08-14T08:08:11-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0000935836-25-000525 2025-08-14T13:52:56-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001628280-25-041688 2025-09-04T19:43:59-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001843113-25-000003 2025-10-21T11:50:04-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-25-000069 2025-11-04T08:06:53-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-q/0001274737-25-000071 2025-11-04T09:20:28-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-26-000003 2026-01-12T09:05:41-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13g/0002042077-26-000013 2026-02-04T14:36:36-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0001140361-26-004799 2026-02-11T16:16:20-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/schedule-13ga/0001493215-26-000034 2026-02-17T08:40:17-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001843113-26-000002 2026-02-25T19:14:10-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001449439-26-000003 2026-02-25T19:14:36-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001843113-26-000004 2026-03-04T15:03:35-05:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/8-k/0001274737-26-000007 2026-03-10T08:05:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/10-k/0001274737-26-000009 2026-03-10T09:27:17-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001843113-26-000006 2026-03-16T19:19:20-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/4/0001449439-26-000005 2026-03-16T19:20:05-04:00 0.4 https://investors.exagen.com/sec-filings/sec-filing/3/0001274737-26-000011 2026-03-16T21:19:36-04:00 0.4 https://investors.exagen.com/board-member/brian-birk 2023-07-25T12:25:39-04:00 0.5 https://investors.exagen.com/board-member/ebetuel-pallares-phd 2023-07-25T12:27:46-04:00 0.5 https://investors.exagen.com/board-member/ron-rocca 2019-09-05T12:42:26-04:00 0.5 https://investors.exagen.com/board-member/james-tullis 2019-09-05T12:43:16-04:00 0.5 https://investors.exagen.com/board-member/chet-brurrell 2019-09-30T14:27:32-04:00 0.5 https://investors.exagen.com/board-member/bruce-robertson 2024-08-07T15:44:31-04:00 0.5 https://investors.exagen.com/board-member/jeff-elliott 2019-09-05T12:46:05-04:00 0.5 https://investors.exagen.com/board-member/tina-nova 2024-08-07T15:44:06-04:00 0.5 https://investors.exagen.com/board-member/wendy-johnson 2023-07-25T12:27:39-04:00 0.5 https://investors.exagen.com/analyst/mark-massaro 2021-04-09T09:19:38-04:00 0.5 https://investors.exagen.com/analyst/kyle-mikson 2022-01-14T19:33:18-05:00 0.5 https://investors.exagen.com/analyst/chris-lin 2025-07-31T19:56:26-04:00 0.5 https://investors.exagen.com/analyst/paul-knight 2021-04-09T09:30:39-04:00 0.5 https://investors.exagen.com/analyst/brian-weinstein 2022-09-15T17:33:17-04:00 0.5 https://investors.exagen.com/analyst/max-masucci 2021-07-08T20:57:51-04:00 0.5 https://investors.exagen.com/board-member/frank-stokes 2024-08-07T15:44:38-04:00 0.5 https://investors.exagen.com/ana-hooker 2024-08-07T15:44:12-04:00 0.5 https://investors.exagen.com/board-member/paul-kim 2024-08-07T15:44:24-04:00 0.5 https://investors.exagen.com/board-member/scott-kahn 2024-08-07T15:44:18-04:00 0.5 https://investors.exagen.com/analyst/bill-bonello 2025-07-31T19:57:25-04:00 0.5 https://investors.exagen.com/chas-mckhann 2025-07-31T20:04:17-04:00 0.5 https://investors.exagen.com/analyst/anderson-schock 2025-09-19T17:37:46-04:00 0.5